Volume 7 Number 8

Editorial
139
A tradition of learning and international exchange in interventional cardiology: a speciality with a “whole-world” embrace

Serruys PW

EuroIntervention 2011;7:889-891

140
Percutaneous coronary interventions in saphenous vein grafts: the more things change, the more they stay the same

Agostoni P, Vermeersch P

EuroIntervention 2011;7:893-895

141
Complications with a happy ending

Muller O, Lerman A, Eeckhout E

EuroIntervention 2011;7:897-899

EAPCI column
142
Rayonnement…

Fajadet J

EuroIntervention 2011;7:901-902

The surgeon's corner
143
What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement?

Kappetein AP, Head S, Treede H, Reichenspurner H, Mohr F, Walther T

EuroIntervention 2011;7:903-904

Clinical research
144
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial

Généreux P, Mehran R, Palmerini T, Caixeta A, Kirtane A, Lansky A, Brodie B, Witzenbichler B, Mockel M, Guagliumi G, Peruga J, Dudek D, Fahy M, Dangas G, Stone G, for the HORIZONS-AMI Trial Investigators

EuroIntervention 2011;7:905-916

145
The impact of fractional flow reserve measurement on clinical outcomes after transradial coronary stenting

Leesar M, Satran A, Yalamanchili V, Helmy T, Abdul-Waheed M, Wongpraparut N

EuroIntervention 2011;7:917-923

146
Radial artery access for above the knee angioplasty: a feasibility study

Lorenzoni R, Mazzoni A, Lazzari M, Boni A, Gemignani C, Bovenzi F

EuroIntervention 2011;7:924-929

147
Comparison of novel 6.5 Fr sheathless guiding catheters versus 5 Fr guiding catheters for transradial coronary intervention

Chiam P, Liu B, Wong A, Wong P, Lim S-T, Koh T-H, Lim V

EuroIntervention 2011;7:930-935

148
Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial

Kang W, Ahn T, Lee K, Han S, Shin E, Jeong M, Yoon J, Park J-S, Bae J, Hur S, Rha S, Oh S, Kim D, Jang Y, Choi J, Kim B

EuroIntervention 2011;7:936-943 publish online ahead of print August 2011

149
The physiological significance of coronary aneurysms in Kawasaki disease

Murakami T, Tanaka N

EuroIntervention 2011;7:944-947

150
Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial

Jeroudi O, Abdel-Karim A-R, Michael T, Lichtenwalter C, de Lemos J, Obel O, Addo T, Roesle M, Haagen D, Rangan B, Raghunathan D, DaSilva M, Saeed B, Bissett J, Sachdeva R, Voudris V, Kariofillis P, Kar B, Roosen J, Fasseas P, Berger P, Banerjee S, Brilakis E

EuroIntervention 2011;7:948-954

151
Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device

Porto I, Belloni F, Niccoli G, Larosa C, Leone A, Burzotta F, Trani C, De Maria G, Hamilton-Craig C, Crea F

EuroIntervention 2011;7:955-961

152
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

Cuculi F, Banning A, Abizaid A, Bartorelli A, Baux A, Dzavik V, Ellis S, Gao R, Holmes D, Jeong M, Legrand V, Neumann F-J, Nyakern M, Spaulding C, Stoll H-P, Worthley S, Urban P, e-SELECT investigators

EuroIntervention 2011;7:962-968

153
Three-year clinical event rates in different age groups after contemporary percutaneous coronary intervention

Kukreja N, Onuma Y, García-García H, van Nierop J, Daemen J, van Domburg R, Serruys PW, on behalf of the interventional cardiologists of the Thoraxcenter (-)

EuroIntervention 2011;7:969-976 publish online ahead of print March 2011

154
Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

Sabate M, Cequier A, Iñiguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, Heijer P, Bethencourt A, Vazquez N, Brugaletta S, Backx B, Serruys PW

EuroIntervention 2011;7:977-984 publish online ahead of print November 2011

Expert review
155
Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

Navarese E, Kubica J, Castriota F, Gibson M, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S

EuroIntervention 2011;7:985-994 publish online ahead of print November 2011

How should I treat?
156
How should I treat a patient with left main disease and a totally occluded left anterior descending artery with a diseased saphenous venous graft?

Abdou S, Hussein H, Wu C-J

EuroIntervention 2011;7:995-1003

Tools & Techniques
157
Tools & Techniques: Alcohol septal ablation for hypertrophic cardiomyopathy

Bertog S, Franke J, Hornung M, Hofmann I, Sievert H

EuroIntervention 2011;7:1004-1005

Image in cardiology
158
A drug-eluting stent, accidentally removed as late as 1½ years after implantation

van der Giessen WJ, Erta? G, van Beusekom H, Schultz C, Ligthart J, van der Linden M, Regar E

EuroIntervention 2011;7:1006-1007

159
Endovascular extraction of a coronary stent: resolution of a cathlab nightmare

Kirchhof P, Reinecke H

EuroIntervention 2011;7:1008

Volume 7 Number 8 has been released thanks to the support of the following partners:
  • Acist Medical
  • Biosensors
  • Boston Scientific
  • Edwards Lifesciences
  • Hexacath
  • Medtronic
  • Minvasys

Online ISSN 1969-6213 - Print ISSN 1774-024X